Following the results of a study by USC Annenberg Inclusion Initiative demonstrating the lack of adequate representation of ...
The pharmaceutical company expects the expansion will create thousands of jobs.
Eli Lilly is doubling its U.S. manufacturing investment since 2020 as it seeks to produce more drugs domestically. Its latest ...
18h
GlobalData on MSNEli Lilly to expand US pharma manufacturing with four new sitesEli Lilly has announced plans to expand its domestic medicine production in the US by establishing four new pharmaceutical ...
Eli Lilly said it plans to build three new plants in the United States to make the key ingredients used in pharmaceuticals, ...
Eli Lilly, the maker of blockbuster weight loss and diabetes drugs Zepbound and Mounjaro, said it will invest an additional ...
Eli Lilly & Co.’s stock rose 1.6% Wednesday, after the drug company announced plans to expand its U.S. manufacturing sites by ...
In this week’s edition of InnovationRx, we look at Eli Lilly’s weight-loss pill stockpiling, scaling stem cell manufacturing, ...
CNBC’s Angelica Peebles and Eli Lilly CEO David Ricks, join 'Squawk on the Street' to discuss the company's U.S.
It comes as companies work to build goodwill with Trump, who has emphasized reshoring manufacturing to the U.S. and reducing ...
Eli Lilly has lowered the price of its weight-loss drug Zepbound for patients paying out of pocket and introduced two new ...
Eli Lilly and Co. is in negotiations with several states and plans to announce the locations of four new manufacturing plants ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results